Authorized purpose: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.
Clinical role
Post-acquisition image upload and frame selection followed by automated vessel segmentation/classification and ROI measurements, with visualization, manual review/editing, and PDF or Excel reporting.
Images and patients
X-ray/Radiography · Coronary arteries and cardiovascular anatomy
Key limitation
Keep in mind: Use is limited to adult coronary-artery disease cases and responsible-clinician review; quantified results must not be the sole or irrefutable basis for diagnosis. The packet's stand-alone performance cohort used 305 US coronary angiograms and does not establish broader patient, system, or local-interface performance.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Coronary arteries and cardiovascular anatomy Input: DICOM X-ray angiographic images of coronary arteries from FDA-approved Philips Medical Systems, Siemens Healthineers, or GE Healthcare X-ray angiography systems; the indication is for adult patients with coronary artery disease.
Who uses it?Intended users: Cardiologists and radiologists.
What does the software produce?Output: Vessel contours, LAD/LCX/RCA vessel classification, percent diameter stenosis, minimum lumen diameter, proximal and distal diameters, ROI length, reference diameter, on-screen analysis, and PDF or Excel exports.
What is its most important limitation?Key limitation: Use is limited to adult coronary-artery disease cases and responsible-clinician review; quantified results must not be the sole or irrefutable basis for diagnosis. The packet's stand-alone performance cohort used 305 US coronary angiograms and does not establish broader patient, system, or local-interface performance.
Clinical takeaway. Clinical role: Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.
Evidence takeaway. Evidence from the reviewed source record: FDA nonclinical stand-alone performance testing used 305 retrospective US coronary angiograms collected from Philips Medical Systems Nederland, with test data segregated from training data. Three features were tested: vessel segmentation, vessel classification, and ROI analysis. Vessel classification accuracy was 0.9934; vessel segmentation Dice similarity coefficient was 0.9200 with a pass criterion >0.8; ROI minimum-lumen-diameter analysis was reported as comparable to the predicate, and all prespecified pass criteria were met. No clinical studies were required for substantial equivalence. The accuracy and Dice values are feature-specific endpoints, not overall diagnostic sensitivity or specificity.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Quantified results from X-ray angiographic images of the coronary arteries to support clinical decisions about diagnosis or treatment evaluation in adult patients with coronary artery disease; results are not the sole basis for diagnosis.
Post-acquisition image upload and frame selection followed by automated vessel segmentation/classification and ROI measurements, with visualization, manual review/editing, and PDF or Excel reporting.
DICOM X-ray angiographic images of coronary arteries from FDA-approved Philips Medical Systems, Siemens Healthineers, or GE Healthcare X-ray angiography systems; the indication is for adult patients with coronary artery disease.
Use is limited to adult coronary-artery disease cases and responsible-clinician review; quantified results must not be the sole or irrefutable basis for diagnosis. The packet's stand-alone performance cohort used 305 US coronary angiograms and does not establish broader patient, system, or local-interface performance.
FDA nonclinical stand-alone performance testing used 305 retrospective US coronary angiograms collected from Philips Medical Systems Nederland, with test data segregated from training data. Three features were tested: vessel segmentation, vessel classification, and ROI analysis. Vessel classification accuracy was 0.9934; vessel segmentation Dice similarity coefficient was 0.9200 with a pass criterion >0.8; ROI minimum-lumen-diameter analysis was reported as comparable to the predicate, and all prespecified pass criteria were met. No clinical studies were required for substantial equivalence. The accuracy and Dice values are feature-specific endpoints, not overall diagnostic sensitivity or specificity.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA nonclinical stand-alone performance testing used 305 retrospective US coronary angiograms collected from Philips Medical Systems Nederland, with test data segregated from training data. Three features were tested: vessel segmentation, vessel classification, and ROI analysis. Vessel classification accuracy was 0.9934; vessel segmentation Dice similarity coefficient was 0.9200 with a pass criterion >0.8; ROI minimum-lumen-diameter analysis was reported as comparable to the predicate, and all prespecified pass criteria were met. No clinical studies were required for substantial equivalence. The accuracy and Dice values are feature-specific endpoints, not overall diagnostic sensitivity or specificity.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
MPXA-2000 regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K222036
Samplen=305
IndependenceIndependence not established
K222036
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K222036. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM X-ray angiographic images of coronary arteries from FDA-approved Philips Medical Systems, Siemens Healthineers, or GE Healthcare X-ray angiography systems; the indication is for adult patients with coronary artery disease.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The stand-alone application accepts DICOM X-ray angiographic data, supports image uploading and frame selection, displays results on screen, and exports PDF or Excel files. The packet identifies validated Philips, Siemens, and GE acquisition systems but does not establish PACS, RIS, EHR, interface versions, or local compatibility.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The exact FDA decision document was reviewed on 2026-11-14 and does not state where the subject device's software runs or how it is hosted. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 ·
Returned objects
Source context, not route validation: Vessel contours, LAD/LCX/RCA vessel classification, percent diameter stenosis, minimum lumen diameter, proximal and distal diameters, ROI length, reference diameter, on-screen analysis, and PDF or Excel exports.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Vessel contours, LAD/LCX/RCA vessel classification, percent diameter stenosis, minimum lumen diameter, proximal and distal diameters, ROI length, reference diameter, on-screen analysis, and PDF or Excel exports.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The stand-alone application accepts DICOM X-ray angiographic data, supports image uploading and frame selection, displays results on screen, and exports PDF or Excel files. The packet identifies validated Philips, Siemens, and GE acquisition systems but does not establish PACS, RIS, EHR, interface versions, or local compatibility.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
24Fields reviewed
9Source classes checked
1Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate record. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission
No public price or quote for the exact K222036 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not publicly available - checked 2026-11-14 - Exact FDA submission
The exact FDA decision document was reviewed on 2026-11-14 and does not state where the subject device's software runs or how it is hosted. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-09 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-09 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Automated measurement of cardiac diameter, thoracic diameter, and the cardiothoracic ratio (CTR) on posterior-anterior chest X-rays to aid physicians or licensed practitioners; not a stand-alone decision tool.
Authorized purpose: Automatic cardiothoracic-ratio assessment on PA chest X-ray images for adults 20-80 years old in healthcare institutions; results support clinician assessment and are not for standalone clinical decision-making.
Modality
X-ray/Radiography
Anatomy
Heart and thoracic cavity for cardiothoracic-ratio measurement
Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.